Table 10.

Differential discounting results for CVD risk without and with diabetes for four risk levels. All dominated strategies have been excluded

	Base case	Lower DR	No DR		Base case	Lower DR	No DR
Strategy	oDR - 3 %	oDR - 1.5 %	oDR - 0 %	Strategy	oDR - 3 %	oDR - 1.5 %	oDR - 0 %
CVD risk
Low risk	ICER			Moderate risk	ICER
No treatment				No treatment
ACEI_Diu	1327	907	585	ACEI_Diu	164	118	082
ACEI_Diu_Sta	3175	2121	1497	ACEI_Diu_Sta	554	379	262
High risk				Very high risk
No treatment				No treatment
ACEI_CCB_Diu	349	252	176	ACEI_CCB_Diu_ASA	498	364	258
ACEI_CCB_Diu_Sta	607	432	293	ACEI_CCB_Diu_Sta_ASA	652	461	315
CVD risk with diabetes
Low risk				Moderate risk
No treatment				No treatment
Sulf_ACEI_CCB	608	465	311	Sulf_ACEI_CCB	115	083	058
Big_Sulf_ACEI_CCB	958	645	430	Big_Sulf_ACEI_CCB	256	179	123
Big_Sulf_ACEI_CCB_Sta	2480	1769	1126	Big_Sulf_ACEI_CCB_Sta	945	675	450
High risk				Very high risk
No treatment				No treatment
Big_Sulf_ACEI_CCB	309	222	154	Big_Sulf_ACEI_CCB_ASA	350	258	184
Big_Sulf_ACEI_CCB_Sta	914	640	436	Big Sulf ACEI CCB Sta ASA	704	505	346
Big Sulf ACEI ARB CCB Sta	10300	7357	4905	Big Sulf ACEI ARB CCB Sta ASA	7615	4950	3536

DR - Discount rate; ICER - Incremental cost-effectiveness ratio